Catheterization During Second Elective Caesarean Delivery (CDSECD)

May 16, 2014 updated by: Salwa Said Ali Wahba, Ain Shams University

Evaluation OF Use Versus Non Use of Urinary Catheterization During Second Elective Caesarean Delivery

Use versus non use of urinary catheterization during Second Elective caesarean delivery:

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Evaluation OF use versus non use of urinary catheterization during Second Elective caesarean delivery:by urine analysis 24 hours postoperative to exclude urinary tract infection.

Study Type

Interventional

Enrollment (Anticipated)

220

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Cairo, Egypt, +20
        • Recruiting
        • AinShamsU
        • Contact:
          • Amr Helmy, Master
          • Phone Number: 01227900014
        • Principal Investigator:
          • Amr Helmy, Master

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 38 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

inclusion criteria

  • pregnant females who will undergo second elective caesarean section at full term pregnancy (38:41 weeks gestational age).

Exclusion Criteria:

  • Women with history of more than one previous caesarean Section.
  • Women with history of a tonic postpartum hemorrhage.
  • Women with Urinary tract infection in present pregnancy.
  • Women with diabetes mellitus in present pregnancy.
  • Women with medical disorder in present pregnancy that obligate monitoring of urine output during and after caesarean section, such as severe pre-eclampsia or renal disease with pregnancy.
  • Emergency caesarean section

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group 1
Use of urinary catheterization in Cesarean section
Device: Foley's Catheter
Urinary tract infection inpatient catheterized versus non catheterized
No Intervention: Group 2
NO urinary catheterization during Cesarean section

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Urine analysis to diagnosed urinary tract infection by leucocytes more than 10 per high power field
Time Frame: participants will be followed for the duration of urinary tract infection,an expected average 2 days.
participants will be followed for the duration of urinary tract infection,an expected average 2 days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ain Shams University

Investigators

  • Principal Investigator: Amr Helmy, Master, Ain Shams University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2013

Primary Completion (Anticipated)

August 1, 2014

Study Completion (Anticipated)

September 1, 2014

Study Registration Dates

First Submitted

May 6, 2014

First Submitted That Met QC Criteria

May 16, 2014

First Posted (Estimate)

May 20, 2014

Study Record Updates

Last Update Posted (Estimate)

May 20, 2014

Last Update Submitted That Met QC Criteria

May 16, 2014

Last Verified

May 1, 2014

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HSM28-10-12

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Wound Infection

Clinical Trials on Foley's Catheter

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe